Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Roberta Artico"'
Publikováno v:
J, Vol 3, Iss 3, Pp 275-288 (2020)
Riluzole 5 mg/mL oral suspension is the only licensed liquid medicine to treat Amyotrophic Lateral Sclerosis (ALS) orally. As more than 80% of ALS patients develop dysphagia, an oral liquid formulation provides an important therapeutic option. The Ri
Externí odkaz:
https://doaj.org/article/f7cb04a5fab84945ad54e4ac686bc1f7
Publikováno v:
J, Vol 3, Iss 21, Pp 275-288 (2020)
J — Multidisciplinary Scientific Journal
Volume 3
Issue 3
Pages 21-288
J — Multidisciplinary Scientific Journal
Volume 3
Issue 3
Pages 21-288
Riluzole 5 mg/mL oral suspension is the only licensed liquid medicine to treat Amyotrophic Lateral Sclerosis (ALS) orally. As more than 80% of ALS patients develop dysphagia, an oral liquid formulation provides an important therapeutic option. The Ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f72cd6ba802bb66b8bdaba8a93aacba
https://www.mdpi.com/2571-8800/3/3/21
https://www.mdpi.com/2571-8800/3/3/21
Autor:
Roberta Artico, Federica Airoldi, Monzani Maria Valmen, Silvia Puccianti, Colombo Giuseppe, Sara Cazzaniga, Barbara Gatti
Publikováno v:
International Journal of Pharmaceutics. 511:1141-1142
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b18a5f5afc5c89f0a9c841b9a50beb6f
https://doi.org/10.1016/j.ijpharm.2016.06.094
https://doi.org/10.1016/j.ijpharm.2016.06.094
Publikováno v:
International Journal of Pharmaceutics. 127:239-244
It has previously been found that the undesirable side effects of enhancers may be reduced, virtually without affecting their promoting absorption actions, when they are used in combination with a cyclodextrin. Many enhancers are amphiphilic moieties
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfbb7747c388abac42d56fd9c609830d
https://doi.org/10.1016/0378-5173(95)04229-6
https://doi.org/10.1016/0378-5173(95)04229-6
Autor:
Patrizia Carpinelli, Paolo Cappella, Walter Croci, D. Berta, Aurelio Marsiglio, Paola Zugnoni, Paola Storici, Maurizio Rocchetti, Jan Klapwijk, Barbara Forte, Enrico Pesenti, Chiara Soncini, Ilaria Candiani, Paola Vianello, Fulvia Roletto, Simona Bindi, Alexander D. Cameron, Dino Severino, Maria Laura Giorgini, Roberta Artico, Jurgen Moll, Roberto Tonani, Daniele Fancelli, Mario Varasi, Rodrigo Bravo
Publikováno v:
Journal of medicinal chemistry. 49(24)
The optimization of a series of 5-phenylacetyl 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives toward the inhibition of Aurora kinases led to the identification of compound 9d. This is a potent inhibitor of Aurora kinases that also shows low nan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd08cc812dadec488b873749bc6bc115
https://pubmed.ncbi.nlm.nih.gov/17125279
https://pubmed.ncbi.nlm.nih.gov/17125279